Addex Therapeutics Ltd (ADXN)
8.010
-0.78
(-8.82%)
USD |
NASDAQ |
May 24, 16:00
8.55
+0.54
(+6.74%)
After-Hours: 20:00
Addex Therapeutics Free Cash Flow: -8.908M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -8.908M |
September 30, 2023 | -11.75M |
June 30, 2023 | -11.87M |
March 31, 2023 | -14.54M |
December 31, 2022 | -17.24M |
September 30, 2022 | -17.15M |
June 30, 2022 | -17.05M |
March 31, 2022 | -18.30M |
December 31, 2021 | -16.12M |
Date | Value |
---|---|
September 30, 2021 | -11.85M |
June 30, 2021 | -12.46M |
March 31, 2021 | -11.81M |
December 31, 2020 | -13.06M |
September 30, 2020 | -13.92M |
June 30, 2020 | -15.67M |
March 31, 2020 | -11.31M |
December 31, 2019 | -9.573M |
Free Cash Flow Range, Past 5 Years
-18.30M
Minimum
Mar 2022
-8.908M
Maximum
Dec 2023
-13.68M
Average
-13.06M
Median
Dec 2020
Free Cash Flow Benchmarks
AC Immune SA | -48.92M |
CRISPR Therapeutics AG | -169.05M |
NLS Pharmaceutics Ltd | -9.684M |
Molecular Partners AG | -68.23M |
MoonLake Immunotherapeutics | -48.91M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.5563M |
Cash from Investing (Quarterly) | -0.0012M |
Cash from Financing (Quarterly) | -0.1643M |
Free Cash Flow Per Share (Quarterly) | -0.775 |
Free Cash Flow to Equity (Quarterly) | -0.5575M |
Free Cash Flow to Firm (Quarterly) | -0.5575M |
Free Cash Flow Yield | -179.7% |